Market Tracker

09/30 4:11am ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

32.70
Delayed Data
As of Sep 29
 -0.98 / -2.91%
Today’s Change
16.64
Today|||52-Week Range
43.30
-8.27%
Year-to-Date
A Critical Couple of Months for Acadia Pharmaceuticals
Sep 22 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close33.68
Today’s open33.50
Day’s range31.92 - 33.89
Volume3,313,299
Average volume (3 months)2,184,217
Market cap$4.0B
Dividend yield--
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-34.28%
Earnings growth (next 5 years)+9.45%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book17.19

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-7.45-4.44%
GRFSGrifols SA-0.22-1.37%
AGNPRAAllergan plc-20.16-2.39%
PTHNPatheon NV+0.03+0.10%
Data as of 09/29/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts